Omeros Corporation
OMER
#6375
Rank
โ‚น81.57 B
Marketcap
โ‚น1,127
Share price
-4.49%
Change (1 day)
297.66%
Change (1 year)

Earnings for Omeros Corporation (OMER)

Earnings in 2025 (TTM): -โ‚น10.33 Billion

According to Omeros Corporation's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚น15.22 Billion a decrease over its 2023 earnings that were of -โ‚น13.88 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Omeros Corporation from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น10.33 Billion-32.16%
2024 -โ‚น15.22 Billion9.63%
2023 -โ‚น13.88 Billion-9.57%
2022 -โ‚น15.35 Billion-30.65%
2021 -โ‚น22.14 Billion86.28%
2020 -โ‚น11.89 Billion99.45%
2019 -โ‚น5.96 Billion-49.91%
2018 -โ‚น11.9 Billion190.77%
2017 -โ‚น4.09 Billion-27.96%
2016 -โ‚น5.68 Billion-17.61%
2015 -โ‚น6.9 Billion1.88%
2014 -โ‚น6.77 Billion87.56%
2013 -โ‚น3.61 Billion
2011 -โ‚น2.65 Billion-8.96%
2010 -โ‚น2.91 Billion45.03%
2009 -โ‚น2 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.502 T-21,832.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น1.020 T-8,959.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
-โ‚น0.38 Billion-96.77%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Eterna Therapeutics
ERNA
-โ‚น0.92 Billion-92.06%๐Ÿ‡บ๐Ÿ‡ธ USA